Pre-order Enquiry
Request Free Sample
Global Self-Monitoring Blood Glucose Strips Market Insights and Forecast to 2028
SKU ID : QYR-20052235 | Publishing Date : 31-Jan-2022 | No. of pages : 113
Request Sample
Request Customization
Check Discounts
Blood glucose strips is a part of the SMBG devices.
Market Analysis and Insights: Global Self-Monitoring Blood Glucose Strips Market
Due to the COVID-19 pandemic, the global Self-Monitoring Blood Glucose Strips market size is estimated to be worth US$ 26330 million in 2022 and is forecast to a readjusted size of US$ 45700 million by 2028 with a CAGR of 9.6% during the review period. Fully considering the economic change by this health crisis, Glucose Oxidase accounting for % of the Self-Monitoring Blood Glucose Strips global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
The hospitals and diagnostic laboratories segment accounted for the majority market share during 2017 and will continue to dominate the market for the next few years. One of the major factors responsible for the growing preference for hospitals and diagnostic laboratories among the patients is the availability of early diagnosis that enables appropriate and prompt intervention to promote health by reducing the overall disease burden.
Global Self-Monitoring Blood Glucose Strips Scope and Segment
Self-Monitoring Blood Glucose Strips market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Self-Monitoring Blood Glucose Strips market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Glucose Oxidase
Glucose Dehydrogenase
Other
Segment by Application
Hospital
Clinic
Household
By Company
Roche Diagnostics
LifeScan
Medtronic
Abbott Laboratories
Becton Dickinson
Beurer
Animas Corporation
Bioptik Technology
DexCom
GlySens
Medisana
Menarini Diagnostics
Nemaura Medical
Nipro Diagnostics
Nova Biomedical
Owen Mumford
Senseonics
TaiDoc Technology
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Market Analysis and Insights: Global Self-Monitoring Blood Glucose Strips Market
Due to the COVID-19 pandemic, the global Self-Monitoring Blood Glucose Strips market size is estimated to be worth US$ 26330 million in 2022 and is forecast to a readjusted size of US$ 45700 million by 2028 with a CAGR of 9.6% during the review period. Fully considering the economic change by this health crisis, Glucose Oxidase accounting for % of the Self-Monitoring Blood Glucose Strips global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
The hospitals and diagnostic laboratories segment accounted for the majority market share during 2017 and will continue to dominate the market for the next few years. One of the major factors responsible for the growing preference for hospitals and diagnostic laboratories among the patients is the availability of early diagnosis that enables appropriate and prompt intervention to promote health by reducing the overall disease burden.
Global Self-Monitoring Blood Glucose Strips Scope and Segment
Self-Monitoring Blood Glucose Strips market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Self-Monitoring Blood Glucose Strips market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Glucose Oxidase
Glucose Dehydrogenase
Other
Segment by Application
Hospital
Clinic
Household
By Company
Roche Diagnostics
LifeScan
Medtronic
Abbott Laboratories
Becton Dickinson
Beurer
Animas Corporation
Bioptik Technology
DexCom
GlySens
Medisana
Menarini Diagnostics
Nemaura Medical
Nipro Diagnostics
Nova Biomedical
Owen Mumford
Senseonics
TaiDoc Technology
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
